File Download
Patent History
- ApplicationPC T/CN2014086416 2014-09-12
- PublicationWO 2015035941 2015-03-19
Patent Family
Supplementary
-
Citations:
- Appears in Collections:
granted patent: USE OF ANNEXIN A3 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TREATING HEPATOCELLULAR CARCINOMA
| Title | USE OF ANNEXIN A3 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TREATING HEPATOCELLULAR CARCINOMA |
|---|---|
| Priority Date | 2013-09-12 US 12/1877061P |
| Inventors | |
| Issue Date | 2015 |
| Citation | WO Patent WO 2015035941. World Intellectual Property Organization (WIPO), PatentScope, 2015 How to Cite? |
| Abstract | Annexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance. |
| Persistent Identifier | http://hdl.handle.net/10722/210481 |
| References |
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2015-06-17T07:02:22Z | - |
| dc.date.available | 2015-06-17T07:02:22Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.citation | WO Patent WO 2015035941. World Intellectual Property Organization (WIPO), PatentScope, 2015 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/210481 | - |
| dc.description.abstract | Annexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance. | - |
| dc.title | USE OF ANNEXIN A3 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TREATING HEPATOCELLULAR CARCINOMA | - |
| dc.type | Patent | - |
| dc.identifier.authority | MA, KWAI YEE STEPHANIE=rp00506 | - |
| dc.identifier.authority | GUAN, XINYUAN=rp00454 | - |
| dc.description.nature | published_or_final_version | - |
| dc.contributor.inventor | GUAN, XINYUAN | - |
| dc.contributor.inventor | MA, KWAI YEE STEPHANIE | - |
| dc.contributor.inventor | TONG, MAN | - |
| patents.identifier.application | PC T/CN2014086416 | - |
| patents.description.assignee | UNIV HONG KONG [CN] | - |
| patents.description.country | World Intellectual Property Organization (WIPO) | - |
| patents.date.publication | 2015-03-19 | - |
| dc.relation.references | W O2007141043 (A3) 2008-03-20 | - |
| dc.relation.references | WO 2007141043 (A2) 2007-12-13 | - |
| patents.identifier.hkutechid | Onco-2013-00467-2 | - |
| patents.date.application | 2014-09-12 | - |
| patents.date.priority | 2013-09-12 US 12/1877061P | - |
| patents.description.cc | wo | - |
| patents.identifier.publication | WO 2015035941 | - |
| patents.relation.family | US 2015071933 (A1) 2015-03-12 | - |
| patents.description.kind | A1 | - |
| patents.type | Patent_granted | - |